or Try an Advanced Search...

    Counter Pharmaceutical Products Stocks List

    Symbol Grade Name % Change
    JNJ F Johnson & Johnson 0.23
    TARO B Taro Pharmaceutical Industries 0.24
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Products Pharmacology Active Pharmaceutical Ingredients Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Contact Lens Contact Lenses Diagnostic Products Dow Jones Component Drug Wholesalers Energy Products Gastrointestinal General Surgery Generic Drug Glucose Health Sciences Hematology Immunology Infection

    Related ETFs - A few ETFs which own one or more of the above listed Counter Pharmaceutical Products stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 22.03
    FLV A American Century Focused Large Cap Value ETF 6.89
    XLV B SPDR Select Sector Fund - Health Care 6.86
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 6.84
    IYH B iShares U.S. Healthcare ETF 6.56
    View all Counter Pharmaceutical Products ETFs...
    Compare ETFs
    Compare IHE to FTXH Compare IHE to IYH Compare XLV to FTXH

        Counter Pharmaceutical Products Stocks Recent News

        Date Stock Title
        May 18 JNJ Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
        May 17 JNJ Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution
        May 17 JNJ J&J-backed startup Rapport files for US IPO
        May 17 JNJ J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
        May 17 JNJ Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more
        May 16 JNJ Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
        May 16 JNJ Johnson & Johnson to Buy Proteologix For $850 Million in Cash
        May 16 JNJ Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
        May 16 JNJ Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
        May 16 JNJ Johnson & Johnson to buy dermatology-focused biotech Proteologix
        May 16 JNJ UPDATE 1-Johnson & Johnson to acquire Proteologix for $850 million
        May 16 JNJ Johnson & Johnson to acquire Proteologix for $850 million
        May 16 JNJ Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
        May 16 JNJ J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
        May 15 JNJ Johnson & Johnson (JNJ) RBC Capital Markets Global Healthcare Conference (Transcript)
        May 15 JNJ 1 No-Brainer Growth Stock to Buy and Hold for 10 Years
        May 15 JNJ Kenvue prices secondary stock offering as Johnson & Johnson exits
        May 15 JNJ Johnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)
        May 14 JNJ Is Ardagh Metal Packaging SA (NYSE:AMBP) the Best High-Dividend Penny Stock to Buy Now?
        May 14 JNJ Is B2Gold Corp (NYSE:BTG) the Best High-Dividend Penny Stock to Buy Now?
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Products Pharmacology Active Pharmaceutical Ingredients Antipsychotic Blood Glucose Monitoring Cardiovascular Disease Contact Lens Contact Lenses Diagnostic Products Dow Jones Component Drug Wholesalers Energy Products Gastrointestinal General Surgery Generic Drug Glucose Health Sciences Hematology Immunology Infection
        Counter Pharmaceutical Products

        Counter Pharmaceutical Products are products that are designed to help people reduce their risk of developing certain diseases or illnesses. These products may include vitamins, minerals, herbal supplements, and other natural remedies. They are often used to treat conditions such as high cholesterol, high blood pressure, diabetes, and obesity.

        Browse All Tags